Home Regulatory USFDA approval for Marksans Pharma  Cetirizine Hydrochloride Tablets

USFDA approval for Marksans Pharma  Cetirizine Hydrochloride Tablets

by admin
0 comment
Marksans Pharma

Summary :

Marksans Pharma Limited (Reuters: MARK.BO; Bloomberg: MRKS IN; NSE: MARKSANS; BSE: 524404) has received final approval from US Food & Drugs Administration for its Abbreviated New Drug Application (ANDA) for over the counter (OTC) Cetirizine Hydrochloride Tablets 5 mg and 10mg.

It is indicated for the treatment of the perennial allergic rhinitis including sneezing, rhinorrhea, postnasal discharge, watery eyes, running nose. The product will be marketed under store brand labels and is comparable to the brand Zyrtec®.

Marksans Pharma

 USFDA approval for Marksans Pharma  Cetirizine Hydrochloride Tablets

Shares of Marksans Pharma Limited was last trading in BSE at Rs. 61.65 as compared to the previous close of Rs. 61.20. The total number of shares traded during the day was 311130 in over 2417 trades.

About Cetirizine Hydrochloride

Cetirizine is a second generation antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.

Cetirizine is used to treat cold or allergy symptoms such as sneezing, itching, watery eyes, or runny nose.

Cetirizine is also used to treat an allergic reaction, itching and swelling caused by chronic urticaria (hives) and minimizes or eliminates the symptoms of perennial allergic rhinitis, seasonal allergic rhinitis, chronic idiopathic urticaria, allergic asthma, physical urticaria, and atopic dermatitis.

 

For more Information: Sign in Websites for Agrochemical & Pharmaceutical Databases:

Website : https://www.chemrobotics.com/ (Agrochemical Databases)

Website : https://chemroboticspharma.com/  (Pharmaceutical Databases)

 

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Our Company

Lorem ipsum dolor sit amet, consect etur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis.

ChemRobotics Times

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Laest News

@2021 – All Right Reserved. Designed and Developed by Ample eBusiness

WP2Social Auto Publish Powered By : XYZScripts.com